Inside the Doctors Studio - Retina: Addressing the nAMD Treatment Burden – A Focus on the Port Delivery System

CME: 1.0

Target Audience

This activity is designed to meet the educational needs of Retina Specialists, Retina Fellows, Ophthalmologists (general/comprehensive), Optometrists, and allied health professionals involved in the treatment of patients with Wet Age-related Macular Degeneration.

Program Overview

Therapeutic options for prevention and management of diabetic eye disease have expanded, as recent trial data (PANORAMA; DRCR Protocol W) have established that therapeutic intervention can reverse disease progression (improvements in Diabetic Retinopathy Severity Scale) in diabetic patients with moderately severe to severe non-proliferative diabetic retinopathy (NPDR) without diabetic macular edema (DME). This treatment of NPDR may go beyond the current treatment algorithm and provide an opportunity to prevent progression to neovascular vision-threatening complications or DME, thereby lowering burden of illness, and enhancing visual outcomes and overall quality of life for patients. Additionally, physicians are faced with new challenges associated with patient care and adherence in the era of COVID-19.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the PDS mechanism of continuous delivery via passive diffusion.
  • Describe the PDS placement and refill procedure.
  • Discuss the clinical trial outcomes of PDS in neovascular AMD.
  • Discuss the benefits of the clinical application of PDS for neovascular AMD patients.

Post a comment to this article